Abstract PD04-02: Clinical Value of Circulating Tumor Cells (CTC) in First Line Metastatic Breast Cancer (MBC) Patients (pts) According to Type of Treatment and Immunohistochemical Molecular SubtypeAntonio Giordano, Massimo Cristofanilli, RH Alvarez et al.|Cancer Research|2010Cited by 3
Abstract P3-02-03: Prognostic Value of Circulating Tumor Cells (CTC) in HER-2 Positive Metastatic Breast Cancer (MBC) Patients (pts) Treated with Anti-HER2-Based TherapyMario Giuliano, Massimo Cristofanilli, Antonio Giordano et al.|Cancer Research|2010Cited by 1